Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.

Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR.

Mol Psychiatry. 2009 Jan;14(1):60-70. Epub 2007 Sep 25.

2.

Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity.

Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B.

Neuroscience. 2010 Oct 27;170(3):782-8. doi: 10.1016/j.neuroscience.2010.07.050. Epub 2010 Aug 1.

PMID:
20678555
3.

Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity.

Nikolova YS, Ferrell RE, Manuck SB, Hariri AR.

Neuropsychopharmacology. 2011 Aug;36(9):1940-7. doi: 10.1038/npp.2011.82. Epub 2011 May 18.

4.

Variation in dopamine genes influences responsivity of the human reward system.

Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):617-22. doi: 10.1073/pnas.0805517106. Epub 2008 Dec 22.

5.

Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype.

Hahn T, Heinzel S, Dresler T, Plichta MM, Renner TJ, Markulin F, Jakob PM, Lesch KP, Fallgatter AJ.

Hum Brain Mapp. 2011 Oct;32(10):1557-65. doi: 10.1002/hbm.21127. Epub 2010 Sep 15.

PMID:
20845394
6.

DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J.

Neuropsychopharmacology. 2010 Nov;35(12):2414-26. doi: 10.1038/npp.2010.124. Epub 2010 Aug 25.

7.

Epistasis effects of dopamine genes on interval timing and reward magnitude in humans.

Balcı F, Wiener M, Cavdaroğlu B, Branch Coslett H.

Neuropsychologia. 2013 Jan;51(2):293-308. doi: 10.1016/j.neuropsychologia.2012.08.002. Epub 2012 Aug 10.

PMID:
22903038
8.

Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making.

Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED.

Neuropsychopharmacology. 2016 Feb;41(3):695-703. doi: 10.1038/npp.2015.192. Epub 2015 Jun 29.

9.

Gene-gene interaction associated with neural reward sensitivity.

Yacubian J, Sommer T, Schroeder K, Gläscher J, Kalisch R, Leuenberger B, Braus DF, Büchel C.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):8125-30. Epub 2007 May 2.

10.

COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.

Heinzel S, Dresler T, Baehne CG, Heine M, Boreatti-Hümmer A, Jacob CP, Renner TJ, Reif A, Lesch KP, Fallgatter AJ, Ehlis AC.

Cereb Cortex. 2013 Jun;23(6):1453-62. doi: 10.1093/cercor/bhs132. Epub 2012 May 22.

PMID:
22617852
11.

DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience.

Peciña M, Mickey BJ, Love T, Wang H, Langenecker SA, Hodgkinson C, Shen PH, Villafuerte S, Hsu D, Weisenbach SL, Stohler CS, Goldman D, Zubieta JK.

Cortex. 2013 Mar;49(3):877-90. doi: 10.1016/j.cortex.2012.01.010. Epub 2012 Feb 14.

12.

Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features.

Gervasini G, Gordillo I, García-Herráiz A, Flores I, Jiménez M, Monge M, Carrillo JA.

J Clin Psychopharmacol. 2013 Aug;33(4):551-5. doi: 10.1097/JCP.0b013e3182970469.

PMID:
23775054
13.

Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.

Sweitzer MM, Donny EC, Hariri AR.

Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S59-71. doi: 10.1016/j.drugalcdep.2012.01.017. Epub 2012 Feb 16. Review.

14.

Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M.

Behav Brain Funct. 2010 Jan 12;6:4. doi: 10.1186/1744-9081-6-4.

15.

The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards.

Camara E, Krämer UM, Cunillera T, Marco-Pallarés J, Cucurell D, Nager W, Mestres-Missé A, Bauer P, Schüle R, Schöls L, Tempelmann C, Rodriguez-Fornells A, Münte TF.

Cereb Cortex. 2010 Aug;20(8):1985-96. doi: 10.1093/cercor/bhp263. Epub 2009 Dec 27.

PMID:
20038544
16.

Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation.

Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P, Puls I, Sander T, Heinz A, Gallinat J.

Neuroimage. 2008 Oct 1;42(4):1631-8. doi: 10.1016/j.neuroimage.2008.06.019. Epub 2008 Jun 25.

PMID:
18634888
17.

A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse.

Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P.

Eur J Neurol. 2006 Sep;13(9):1009-13.

PMID:
16930369
18.

Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity.

Congdon E, Lesch KP, Canli T.

Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):27-32.

PMID:
17525955
19.

Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype.

Mueller EM, Makeig S, Stemmler G, Hennig J, Wacker J.

J Neurosci. 2011 Nov 2;31(44):15818-25. doi: 10.1523/JNEUROSCI.2103-11.2011.

20.

Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release.

Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Düzel E, Bauer A.

J Neurosci. 2008 Dec 24;28(52):14311-9. doi: 10.1523/JNEUROSCI.2058-08.2008.

Supplemental Content

Support Center